Moolec Science SA (NASDAQ:MLEC) shares rose in Tuesday’s premarket session, outperforming a weaker broader market as Nasdaq futures fell 1.20% and S&P 500 futures declined 0.63%, pointing to stock-specific momentum.
The move follows a technical rebound, with the stock pushing above key short-term averages after a prolonged downtrend.
Traders appear to be positioning around mean-reversion setups in smaller names amid a mixed market backdrop.
In early April, Moolec reported a breakthrough in molecular farming. The company said it successfully achieved stable expression of bovine myoglobin in pea seeds, marking the outcome of a 28-month research project with a U.S. academic partner.
The milestone expands Moolec’s platform and could unlock more scalable protein production pathways.
It also strengthens its positioning in alternative proteins, where myoglobin plays a key role in delivering meat-like taste and color.
Moolec Science Stock: Key Levels To Watch
Moolec’s chart is still trying to stabilize after a steep 52-week drawdown, and it remains far below its longer-term trend markers. The stock is trading 4.6% above its 20-day SMA and 14.3% above its 100-day SMA.
This suggests improving near-term traction, even as the broader trend remains uneven.
MACD is above the signal line with a positive histogram, indicating momentum is firming from a low base.
Over the last 12 months, the stock has been down 91.59%, which highlights how much longer-term damage still overhangs any rebound attempts.
Within the 52-week range ($3.08 to $157.05), the current zone is much closer to the low than the high, so traders often treat strength here as a recovery attempt rather than a fully restored uptrend.
- Key Resistance: $9.50 — near the 50-day SMA area where rebounds can stall.
- Key Support: $7.00 — a line buyers have defended, and a key “floor” to watch.
What Is Moolec Science?
Moolec Science SA is a science-based ingredient company that produces real animal proteins in plants through molecular farming.
It operates within the alternative protein space, focusing on innovation in food production technologies. Its goal is to improve taste, nutrition, affordability, and sustainability in alternative protein products.
The company’s pipeline includes TSP Valorasoy, a soy protein designed to deliver a meat-like texture. It also includes Glaso, a safflower oil rich in gamma-linolenic acid, and SPC2, a plant-based chymosin.
Another product, YEEA1, is an extract derived from a novel yeast biomass, while most revenue comes from Argentina.
Moolec Science Benzinga Edge Momentum Analysis
Below is the Benzinga Edge scorecard for Moolec Science SA Ordinary Shares, highlighting its strengths and weaknesses compared to the broader market:
- Momentum: Weak (Score: 4.42) — The stock’s trend profile remains fragile versus the broader market.
The Verdict: Moolec Science’s Benzinga Edge signal shows momentum remains bearish, suggesting the premarket pop is likely a short-term bounce, not a trend reversal.
MLEC Price Action: Moolec Science shares were up 0.99% at $8.17 at the time of publication on Tuesday. The stock is near its 52-week low of $3.07, according to Benzinga Pro data.
Image via Shutterstock
Recent Comments